Literature DB >> 293691

Enhancement of hexose uptake in human polymorphonuclear leukocytes by activated complement component C5a.

C E McCall, D A Bass, S Cousart, L R DeChatelet.   

Abstract

The polymorphonuclear leukocyte (PMNL) depends on glucose as a source of energy for motility, chemotaxis, phagocytosis, and bactericidal activity. Activated complement (C5a) at low concentrations stimulates carrier-mediated carbohydrate transport in PMNLs as measured by the uptake of 2-deoxy-D-[(3)H]glucose. Human PMNLs were preincubated at 37 degrees C for 15 min with zymosan-activated human serum or various purified preparations of human C5a. A concentration-dependent increase in deoxyglucose transport (>700% of control) into PMNLs occurred with all test substances. Reaction was linear for 30 min, and uptake of deoxyglucose followed saturation kinetics. C5a caused a decrease in the K(m) for deoxyglucose, from 0.53 to 0.11 mM, without altering the V(max) (44 nmol/30 min per 5 x 10(6) PMNLs in control and 46.6 with C5a). The optimal concentration of C5a for enhanced carrier-mediated transport of deoxyglucose was similar to that which promoted optimal chemotaxis. Activated serum from C5-deficient mice had little or no effect on deoxyglucose transport whereas that from normal syngeneic mice enhanced deoxyglucose transport. C5a did not enhance deoxyglucose transport into isolated erythrocytes, platelets, or lymphocytes. The deoxyglucose within the cell was primarily in the phosphorylated form, and hexokinase activity was not increased in PMNLs stimulated with C5a, indicating that hexokinase was not rate limiting and that enhanced transport was the mechanism of the C5a activity. Insulin at physiologic concentration (10 ng/ml) had no effect on deoxyglucose transport in PMNL and did not act as a competitive inhibitor of C5a. This insulin-like bioactivity could be detected with the amount of C5a that would be present after activation of 0.1-0.5% of the C5 in 1 ml of serum. This suggests that uptake of [(3)H]deoxyglucose by PMNLs might serve as a highly sensitive test for activation of the fifth component of complement.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 293691      PMCID: PMC411759          DOI: 10.1073/pnas.76.11.5896

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  Complement abnormalities in human disease.

Authors:  H J Müller-Eberhard
Journal:  Hosp Pract       Date:  1978-12

2.  Independent stimulation of motility and the oxidative metabolic burst of human polymorphonuclear leukocytes.

Authors:  D A Bass; L R Dechatelet; C E McCall
Journal:  J Immunol       Date:  1978-07       Impact factor: 5.422

3.  Initiation of the respiratory burst in human polymorphonuclear neutrophils: a critical review.

Authors:  L R DeChatelet
Journal:  J Reticuloendothel Soc       Date:  1978-07

4.  Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions.

Authors:  H N Fernandez; P M Henson; A Otani; T E Hugli
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

5.  Effect of intravascular complement activation on granulocyte adhesiveness and distribution.

Authors:  J T O'Flaherty; P R Craddock; H S Jacob
Journal:  Blood       Date:  1978-04       Impact factor: 22.113

6.  Mechanisms of the ability of insulin to activate the glucose-transport system in rat adipocytes.

Authors:  J M Olefsky
Journal:  Biochem J       Date:  1978-04-15       Impact factor: 3.857

7.  Characteristics of human erythrocyte insulin receptors.

Authors:  K K Gambhir; J A Archer; C J Bradley
Journal:  Diabetes       Date:  1978-07       Impact factor: 9.461

8.  Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes.

Authors:  D E Chenoweth; T E Hugli
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

9.  Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes.

Authors:  P R Craddock; J Fehr; A P Dalmasso; K L Brighan; H S Jacob
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

10.  Extracellular cytolysis by activated macrophages and granulocytes. II. Hydrogen peroxide as a mediator of cytotoxicity.

Authors:  C F Nathan; S C Silverstein; L H Brukner; Z A Cohn
Journal:  J Exp Med       Date:  1979-01-01       Impact factor: 14.307

View more
  14 in total

1.  Impaired glucose transport in polymorphonuclear leukocytes in glycogen storage disease Ib.

Authors:  N Bashan; R Potashnik; Y Hagay; S W Moses
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

2.  Metabolic spectroscopy of inflammation in a bleomycin-induced lung injury model using hyperpolarized 1-(13) C pyruvate.

Authors:  Hoora Shaghaghi; Stephen Kadlecek; Charuhas Deshpande; Sarmad Siddiqui; Daniel Martinez; Mehrdad Pourfathi; Hooman Hamedani; Masaru Ishii; Harrilla Profka; Rahim Rizi
Journal:  NMR Biomed       Date:  2014-05-28       Impact factor: 4.044

3.  Comparison of the calcium ionophore and phorbol myristate acetate on the initiation of the respiratory burst in human neutrophils.

Authors:  L R DeChatelet; C J Lees; C E Walsh; G D Long; P S Shirley
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

Review 4.  Assessment of lung inflammation with 18F-FDG PET during acute lung injury.

Authors:  Nicolas de Prost; Mauro R Tucci; Marcos F Vidal Melo
Journal:  AJR Am J Roentgenol       Date:  2010-08       Impact factor: 3.959

5.  G-CSF improves murine G6PC3-deficient neutrophil function by modulating apoptosis and energy homeostasis.

Authors:  Hyun Sik Jun; Young Mok Lee; Ki Duk Song; Brian C Mansfield; Janice Y Chou
Journal:  Blood       Date:  2011-02-03       Impact factor: 22.113

6.  Comparison of human eosinophils from normals and patients with eosinophilia.

Authors:  D A Bass; W H Grover; J C Lewis; P Szejda; L R DeChatelet; C E McCall
Journal:  J Clin Invest       Date:  1980-12       Impact factor: 14.808

7.  Styrene oxidation to styrene oxide in human erythrocytes is catalyzed by oxyhemoglobin.

Authors:  F Tursi; M Samaia; M Salmona; G Belvedere
Journal:  Experientia       Date:  1983-06-15

8.  Neutrophil-endothelial cell interaction. Evidence for and mechanisms of the self-protection of bovine microvascular endothelial cells from hydrogen peroxide-induced oxidative stress.

Authors:  A Dobrina; P Patriarca
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

9.  Impaired carbohydrate metabolism of polymorphonuclear leukocytes in glycogen storage disease Ib.

Authors:  N Bashan; Y Hagai; R Potashnik; S W Moses
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

10.  Granulocytes utilize different energy sources for movement and phagocytosis.

Authors:  D J Weisdorf; P R Craddock; H S Jacob
Journal:  Inflammation       Date:  1982-09       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.